Retatrutide
Retatrutide is a GLP-1 / GIP / glucagon triple receptor agonist researched for its role in metabolism, appetite regulation, glucose control and body composition. Published Phase II clinical protocols most commonly report subcutaneous administration in the 2–12 mg range once weekly, with gradual dose titration. Available in 5 mg and 10 mg vials. Lyophilized powder, ≥98% purity, HPLC-verified with per-batch certificate of analysis.
€199.00
5 mg vialIn Stock
Details
Retatrutide is a GLP-1 / GIP / glucagon triple receptor agonist researched for its role in metabolism, appetite regulation, glucose control and body composition. Published Phase II clinical protocols most commonly report subcutaneous administration in the 2–12 mg range once weekly, with gradual dose titration. Available in 5 mg and 10 mg vials. Lyophilized powder, ≥98% purity, HPLC-verified with per-batch certificate of analysis.
98%+ Purity
Third-party lab verified
Cold Chain
Temperature controlled
Fast Shipping
Same-day dispatch
Research Grade
For research use only
Storage
Store refrigerated at 2-8°C. Protect from light. Keep in original packaging until use.
Specifications
Format: Lyophilized powder. Purity: ≥98%. For research use only.
Retatrutide
€199.00
Free shipping within Bulgaria on orders over €150
Same-day dispatch